首页> Annals of oncology : official journal of the European Society for Medical Oncology> Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer.

Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer.

导出 OA

翻译打印收藏纠错

第一作者： N,Guibert

第一单位： Translational Research Laborator, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.

作者： N,Guibert ^[1] ; Y,Hu ^[2] ; N,Feeney ^[3] ; Y,Kuang ^[3] ; V,Plagnol ^[4] ; G,Jones ^[4] ; K,Howarth ^[4] ; J F,Beeler ^[4] ; C P,Paweletz ^[3] ; G R,Oxnard ^[5]

作者单位： Translational Research Laborator, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA. ^[1] Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA. ^[2] Translational Research Laborator, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA. ^[3] Inivata Ltd, Morrisville, USA. ^[4] Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Boston, USA. Electronic address: geoffrey_oxnard@dfci.harvard.edu. ^[5]

医学主题词癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);抗药性, 肿瘤(Drug Resistance, Neoplasm);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);人类(Humans);肺肿瘤(Lung Neoplasms);突变(Mutation)

DOI 10.1093/annonc/mdy005

PMID 29325035

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交